Experiments on proliferation, apoptosis, and the cell cycle after manipulating MYL12A demonstrated that knocking down MYL12A similarly led to G1/G0 phase arrest and decreased survival capability in DLBCL cells (Figs. 5A–F, S5B–G). Here, MYL12A is linked to diffuse large B-cell lymphoma.